GL Sciences Inc

Chart & Performance

D1W1MN

P/E

8.48

P/S

0.78

EPS

334.38

Div Yield, %

2.29%

Shrs. gr., 5y

—

Rev. gr., 5y

8.42%

Revenues

37.15b

-3.96%

Net income

3.43b

-1.95%

CFO

3.53b

+77.52%

Dividend

Mar 28, 202470 JPY/sh

Profile

GL Sciences Inc. provides gas/liquid chromatography equipment, pretreatment equipment, components, fillers, analytical columns, solid phase, and peripheral equipment in Japan and internationally. The company offers sample preparation products, including solid phase extraction columns and accessories, vials, syringes, disposable filters, certified reference materials, cells, and gas sampling, as well as life sciences/bio and tubing products. It also provides liquid chromatography products, such as LC/MS columns and accessories; gas chromatography comprising GC/MS capillary columns and accessories, GC packed columns and absorbents, GC packed columns accessories, and GC instruments, as well as technical support services; and gastec detector tubes. In addition, the company offers quartz tools for use in semiconductor production; analytical instrumentation for gas chromatography systems; and LC related products, such as valves, degassers, pumps, and related products, as well as engages in the automated recognition business. It serves environmental and water, food and beverage, cosmetics, life science, metal and mining, energy, petrochemical and general chemistry, and automotive and interior material industries. The company was formerly known as gas Chromatography Industrial Co., Ltd. and changed its name to GL Sciences Inc. in October 1990. GL Sciences Inc. was founded in 1968 and is headquartered in Tokyo, Japan.

URL

https://www.gls.co.jp/

IPO date

Mar 03, 2005

Employees

1,144

Domiciled in

Incorporated in

Valuation

Order:

Title JPY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title JPY in thousands, except ratios and share amounts	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03	2015‑03
Income
Revenues	37,148,173 -3.96%	38,679,841 16.79%	33,119,805 13.36%
Cost of revenue	24,645,039	26,110,021	22,673,020
Unusual Expense (Income)
NOPBT	12,503,134	12,569,820	10,446,785
NOPBT Margin	33.66%	32.50%	31.54%
Operating Taxes	1,880,260	1,978,932	1,449,779
Tax Rate	15.04%	15.74%	13.88%
NOPAT	10,622,874	10,590,888	8,997,006
Net income	3,430,655 -1.95%	3,499,060 25.18%	2,795,295 23.84%
Dividends	(665,838)	(512,727)	(409,470)
Dividend yield	2.36%	2.17%	1.57%
Proceeds from repurchase of equity	(105)	3,128,654	(41,074)
BB yield	0.00%	-13.22%	0.16%
Debt
Debt current	3,276,871	2,868,066	2,113,390
Long-term debt	3,569,542	4,299,542	1,997,719
Deferred revenue	138,507	316,712	253,769
Other long-term liabilities	452,827	586,462	494,227
Net debt	(3,987,702)	(2,837,989)	(5,047,157)
Cash flow
Cash from operating activities	3,526,684	1,986,658	3,690,928
CAPEX	(1,634,935)	(3,158,868)	(2,777,792)
Cash from investing activities	(1,685,376)	(3,596,261)	(2,948,351)
Cash from financing activities	(1,188,298)	1,891,084	(1,143,671)
FCF	7,267,535	4,237,079	5,933,777
Balance
Cash	7,451,146	6,556,597	6,119,266
Long term investments	3,382,969	3,449,000	3,039,000
Excess cash	8,976,706	8,071,605	7,502,276
Stockholders' equity	38,903,733	34,272,957	30,223,456
Invested Capital	38,431,744	34,204,031	27,959,184
ROIC	29.25%	34.07%	34.16%
ROCE	25.97%	29.66%	29.38%
EV
Common stock shares outstanding	10,260	10,260	10,260
Price	2,752.00 19.29%	2,307.00 -8.99%	2,535.00 1.73%
Market cap	28,234,887 19.29%	23,669,303 -8.99%	26,008,590 1.72%
EV	30,813,211	26,519,208	25,687,557
EBITDA	14,232,116	14,158,383	11,634,234
EV/EBITDA	2.17	1.87	2.21
Interest	52,692	34,624	31,191
Interest/NOPBT	0.42%	0.28%	0.30%